AIT Bioscience

About:

AIT Bioscience offers bioanalytical contract research services for preclinical and clinical trials.

Website: http://aitbioscience.com

Twitter/X: aitbioscience

Top Investors: Halo

Description:

AIT Bioscience offers bioanalytical contract research services for pre-clinical and phases I to III clinical trials. The company provides drug discovery analyses, protein analysis, and uses ligand-binding assays to provide immunogenicity information to support clinical and non-clinical studies. It employs electronic systems that detect and resolve potential deviations and errors in real-time. AIT Bioscience, operating as a subsidiary of the American Institute of Toxicology, was founded in 2009 and is based in Indianapolis, Indiana.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2009-01-01

Founders:

Michael A. Evans

Number of Employees:

251-500

Last Funding Date:

2015-01-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai